Speaking of Dr. Sharfstein, what's the status of that pediatric cough/cold petition? FDA is still working on a proposed rule to amend the monograph. Read about that in the Tan Sheet here.
Meanwhile, the trade association for OTC drug manufacturers, the Consumer Healthcare Products Association, has filed comments with the agency saying an OTC-to-Rx unswitch of the products would have a negative public health impact. Read their 384 pages of comment here. Or read The Tan Sheet's story here or below:
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about misuse of the products, the Consumer Healthcare Products Association says.
Continue reading "CHPA Opposes Reverse Switch for Pediatric Cold Drugs" »


